UnitedHealth Group Incorporated (NYSE:UNH) is Harbor Investment Advisory LLC’s 7th Largest Position

Harbor Investment Advisory LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,946 shares of the healthcare conglomerate’s stock after purchasing an additional 1,129 shares during the quarter. UnitedHealth Group makes up 1.7% of Harbor Investment Advisory LLC’s portfolio, making the stock its 7th biggest holding. Harbor Investment Advisory LLC’s holdings in UnitedHealth Group were worth $17,783,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in UNH. Richelieu Gestion SA purchased a new position in UnitedHealth Group during the 4th quarter valued at approximately $26,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5 %

Shares of UNH stock opened at $489.99 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The stock’s fifty day moving average price is $497.89 and its 200 day moving average price is $503.21. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market cap of $450.98 billion, a price-to-earnings ratio of 29.95, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.71%. The ex-dividend date of this dividend is Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays raised their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, Robert W. Baird began coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price for the company. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.